GlassScriptPhysician profile
David L Furman
NPI 1124091392
$2,587.30
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,574 · 2020: $768 · 2021: $149 · 2022: $95.91.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $942.58 | 2019-2021 | |
| Abbvie INC. | $301.69 | 2019-2021 | |
| Pfizer INC. | $242.92 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $197.63 | 2019-2021 | |
| Gilead Sciences, INC. | $167.48 | 2019-2021 | |
| Janssen Biotech, INC. | $150.23 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $144.87 | 2019-2020 | |
| Abbott Laboratories | $95.91 | 2022 | |
| Ferring Pharmaceuticals INC. | $86.20 | 2019-2020 | |
| Allergan, INC. | $64.49 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $33.66 | 2019-2020 | |
| Ucb, INC. | $31.89 | 2019 | |
| Redhill Biopharma INC. | $31.48 | 2020 | |
| Braintree Laboratories, INC. | $29.18 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $23.25 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $15.80 | 2020 | |
| Vivus LLC | $14.92 | 2019 | |
| Daiichi Sankyo INC. | $13.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Furman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.